Global Pertussis Vaccine Market Analysis and Forecast 2024-2030

Global Pertussis Vaccine Market Analysis and Forecast 2024-2030


Summary

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

According to APO Research, The global Pertussis Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pertussis Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pertussis Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pertussis Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pertussis Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pertussis Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pertussis Vaccine sales, projected growth trends, production technology, application and end-user industry.

Pertussis Vaccine segment by Company

Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Pertussis Vaccine segment by Type

Whole-cell Vaccines
Acellular Vaccines
Pertussis Vaccine segment by Application

12 Months Below
12 Months Above
Pertussis Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Pertussis Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertussis Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Pertussis Vaccine Market by Type
1.2.1 Global Pertussis Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Pertussis Vaccine Market by Application
1.3.1 Global Pertussis Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Pertussis Vaccine Market Dynamics
2.1 Pertussis Vaccine Industry Trends
2.2 Pertussis Vaccine Industry Drivers
2.3 Pertussis Vaccine Industry Opportunities and Challenges
2.4 Pertussis Vaccine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Pertussis Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Pertussis Vaccine Revenue by Region
3.2.1 Global Pertussis Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pertussis Vaccine Revenue by Region (2019-2024)
3.2.3 Global Pertussis Vaccine Revenue by Region (2025-2030)
3.2.4 Global Pertussis Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Pertussis Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Pertussis Vaccine Sales by Region
3.4.1 Global Pertussis Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Pertussis Vaccine Sales by Region (2019-2024)
3.4.3 Global Pertussis Vaccine Sales by Region (2025-2030)
3.4.4 Global Pertussis Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Pertussis Vaccine Revenue by Manufacturers
4.1.1 Global Pertussis Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Pertussis Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Pertussis Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pertussis Vaccine Sales by Manufacturers
4.2.1 Global Pertussis Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Pertussis Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Pertussis Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Pertussis Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Pertussis Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Pertussis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Pertussis Vaccine Manufacturers, Product Type & Application
4.7 Global Pertussis Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Pertussis Vaccine Market CR5 and HHI
4.8.2 2023 Pertussis Vaccine Tier 1, Tier 2, and Tier 3
5 Pertussis Vaccine Market by Type
5.1 Global Pertussis Vaccine Revenue by Type
5.1.1 Global Pertussis Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Pertussis Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Pertussis Vaccine Sales by Type
5.2.1 Global Pertussis Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Pertussis Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Pertussis Vaccine Price by Type
6 Pertussis Vaccine Market by Application
6.1 Global Pertussis Vaccine Revenue by Application
6.1.1 Global Pertussis Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Pertussis Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Pertussis Vaccine Sales by Application
6.2.1 Global Pertussis Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Pertussis Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Pertussis Vaccine Price by Application
7 Company Profiles
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Comapny Information
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
7.1.5 Sanofi Pasteur Recent Developments
7.2 GSK
7.2.1 GSK Comapny Information
7.2.2 GSK Business Overview
7.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 GSK Pertussis Vaccine Product Portfolio
7.2.5 GSK Recent Developments
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Comapny Information
7.3.2 Mitsubishi Tanabe Pharma Business Overview
7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
7.3.5 Mitsubishi Tanabe Pharma Recent Developments
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Comapny Information
7.4.2 Wuhan Institute of Biological Products Business Overview
7.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
7.4.5 Wuhan Institute of Biological Products Recent Developments
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Comapny Information
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
7.5.5 Walvax Biotechnology Recent Developments
7.6 Minhai Biotechnology
7.6.1 Minhai Biotechnology Comapny Information
7.6.2 Minhai Biotechnology Business Overview
7.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
7.6.5 Minhai Biotechnology Recent Developments
7.7 KM Biologics
7.7.1 KM Biologics Comapny Information
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 KM Biologics Pertussis Vaccine Product Portfolio
7.7.5 KM Biologics Recent Developments
7.8 Chengdu Institute of Biological Products
7.8.1 Chengdu Institute of Biological Products Comapny Information
7.8.2 Chengdu Institute of Biological Products Business Overview
7.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
7.8.5 Chengdu Institute of Biological Products Recent Developments
8 North America
8.1 North America Pertussis Vaccine Market Size by Type
8.1.1 North America Pertussis Vaccine Revenue by Type (2019-2030)
8.1.2 North America Pertussis Vaccine Sales by Type (2019-2030)
8.1.3 North America Pertussis Vaccine Price by Type (2019-2030)
8.2 North America Pertussis Vaccine Market Size by Application
8.2.1 North America Pertussis Vaccine Revenue by Application (2019-2030)
8.2.2 North America Pertussis Vaccine Sales by Application (2019-2030)
8.2.3 North America Pertussis Vaccine Price by Application (2019-2030)
8.3 North America Pertussis Vaccine Market Size by Country
8.3.1 North America Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Pertussis Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Pertussis Vaccine Market Size by Type
9.1.1 Europe Pertussis Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Pertussis Vaccine Sales by Type (2019-2030)
9.1.3 Europe Pertussis Vaccine Price by Type (2019-2030)
9.2 Europe Pertussis Vaccine Market Size by Application
9.2.1 Europe Pertussis Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Pertussis Vaccine Sales by Application (2019-2030)
9.2.3 Europe Pertussis Vaccine Price by Application (2019-2030)
9.3 Europe Pertussis Vaccine Market Size by Country
9.3.1 Europe Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Pertussis Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Pertussis Vaccine Market Size by Type
10.1.1 China Pertussis Vaccine Revenue by Type (2019-2030)
10.1.2 China Pertussis Vaccine Sales by Type (2019-2030)
10.1.3 China Pertussis Vaccine Price by Type (2019-2030)
10.2 China Pertussis Vaccine Market Size by Application
10.2.1 China Pertussis Vaccine Revenue by Application (2019-2030)
10.2.2 China Pertussis Vaccine Sales by Application (2019-2030)
10.2.3 China Pertussis Vaccine Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Pertussis Vaccine Market Size by Type
11.1.1 Asia Pertussis Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Pertussis Vaccine Sales by Type (2019-2030)
11.1.3 Asia Pertussis Vaccine Price by Type (2019-2030)
11.2 Asia Pertussis Vaccine Market Size by Application
11.2.1 Asia Pertussis Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Pertussis Vaccine Sales by Application (2019-2030)
11.2.3 Asia Pertussis Vaccine Price by Application (2019-2030)
11.3 Asia Pertussis Vaccine Market Size by Country
11.3.1 Asia Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Pertussis Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Pertussis Vaccine Market Size by Type
12.1.1 MEALA Pertussis Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Pertussis Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Pertussis Vaccine Price by Type (2019-2030)
12.2 MEALA Pertussis Vaccine Market Size by Application
12.2.1 MEALA Pertussis Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Pertussis Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Pertussis Vaccine Price by Application (2019-2030)
12.3 MEALA Pertussis Vaccine Market Size by Country
12.3.1 MEALA Pertussis Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Pertussis Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Pertussis Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Pertussis Vaccine Value Chain Analysis
13.1.1 Pertussis Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Pertussis Vaccine Production Mode & Process
13.2 Pertussis Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Pertussis Vaccine Distributors
13.2.3 Pertussis Vaccine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings